Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?

There have been several proposed changes for the 8th edition of the American Joint Commission on Cancer (AJCC) for pancreatic adenocarcinoma. The aim of this study was to evaluate the prognostic value of the new staging system for patients with pancreatic adenocarcinoma, especially in stage III patients.

Source: European Journal of Cancer - October 13, 2018 Category: Cancer & Oncology Authors: Meiying Song, Seung Bae Yoon, In Seok Lee, Tae Ho Hong, Ho Joong Choi, Moon Hyung Choi, Myung Ah Lee, Eun Sun Jung, Myung-Gyu Choi Tags: Original Research Source Type: research